H

Healthequity

Europe, Catalonia, Spain, Barcelona

Description

Healthequity specializes in early-stage projects in the health sector: medical devices, biotechnology and healthcare services.

Investor Profile

Healthequity has made 10 investments, with 0 in the past 12 months and 10% as lead.

Stage Focus

  • Series Unknown (30%)
  • Series B (20%)
  • Series A (20%)
  • Series D (10%)
  • Series C (10%)
  • Seed (10%)

Country Focus

  • Spain (80%)
  • Switzerland (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Hospital
  • Oncology
  • Wellness
  • Health Diagnostics
  • Therapeutics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Healthequity frequently co-invest with?

Criteria Venture Tech
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 3
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 2
EV
Europe, Noord-Holland, The Netherlands, Hoofddorp
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
Alta Life Sciences
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2

What are some of recent deals done by Healthequity?

Peptomyc

Barcelona, Catalonia, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

BiotechnologyHealth CareOncologyWellness
Series UnknownJan 18, 2022
Amount Raised: $3,262,609
Peptomyc

Barcelona, Catalonia, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

BiotechnologyHealth CareOncologyWellness
Series UnknownDec 15, 2020
Amount Raised: $13,856,173
Versantis

Zürich, Zurich, Switzerland

Versantis is a pharmaceutical company developing medicine to revolutionize the care of patients.

Health CareHealth DiagnosticsPharmaceuticalTherapeutics
Series BSep 18, 2019
Amount Raised: $16,046,406
SANIFIT

Palma De Mallorca, Islas Baleares, Spain

SANIFIT is a biotechnology company that develops treatments for patients with calcification disorders.

BiotechnologyHospitalMedical
Series DJun 26, 2019
Amount Raised: $62,782,564
Versantis

Zürich, Zurich, Switzerland

Versantis is a pharmaceutical company developing medicine to revolutionize the care of patients.

Health CareHealth DiagnosticsPharmaceuticalTherapeutics
Series AMar 29, 2017
Amount Raised: $4,414,435
Peptomyc

Barcelona, Catalonia, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

BiotechnologyHealth CareOncologyWellness
SeedApr 27, 2016
Amount Raised: $1,132,738
Minoryx Therapeutics

Barcelona, Catalonia, Spain

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series AOct 14, 2015
Amount Raised: $22,259,679
SANIFIT

Palma De Mallorca, Islas Baleares, Spain

SANIFIT is a biotechnology company that develops treatments for patients with calcification disorders.

BiotechnologyHospitalMedical
Series CSep 8, 2015
Amount Raised: $41,013,918
Minoryx Therapeutics

Barcelona, Catalonia, Spain

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series UnknownApr 9, 2015
Amount Raised: $799,804
SANIFIT

Palma De Mallorca, Islas Baleares, Spain

SANIFIT is a biotechnology company that develops treatments for patients with calcification disorders.

BiotechnologyHospitalMedical
Series BAug 21, 2014
Amount Raised: $4,781,054